NEWS: Technology Trends on Diabetes Monitors Market (2020-2023) | MRFR

Diabetes Monitors Market - Overview

Diabetes monitors are used for monitoring glucose levels in the human bodies to optimize treatment strategies and provide insight into the effect of diet, medications, and exercise on the patient. As a cure for diabetes is yet to be developed so, managing this condition is the most successful means for its control. 

Hence, diabetes monitors are essential and highly effective components for the disease management regime. Owing to the increasing prevalence of diabetes the diabetes monitors market is growing pervasively.  Moreover, factors such as the technological advancements, are escalating the market on the global level. 

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/4781 

Acknowledging the exponential upsurges, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global diabetes monitors market will reach USD 17458.1 MN by 2023, registering approximately 8.3% CAGR throughout the forecast period (2017-2023).

Additional factors boosting the market growth include huge research funding in diabetes diagnosis and treatment and rising approval from regulatory bodies. Huge technological advancements and the vast uptake of smart technology drives the growth of the diabetes monitors market. 

On the flip side, factors impeding the growth of the global diabetes monitors market include the high cost associated with these monitors and the stringent FDA approvals & reimbursement policies. Nevertheless, factors such as the increasing demand for these diabetes monitors are expected to support market growth.

Global Diabetes Monitors Market – Segments

MRFR has segmented the report into five key dynamics for an easy grasp;

By Sample: Blood, Sweat, and Urine Samples.

By Type: Point Sample Test-based Glucose Monitors, and Continuous Glucose Monitors (CGM) among others. 

By Component: Lancet, Glucose Test Strips, and Sensors (Enzyme-based and Enzyme-free Sensors) among others. 

By End-users:  Diagnostic Clinics, Hospitals, and Home among others.

By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.

Global Diabetes Monitors Market – Geographical Analysis 

North America accounts for the leading position in the worldwide diabetes monitors market followed by the European and Asia Pacific regions, respectively. The region is expected to reach USD 6623.4 MN by 2023. 

Factors substantiating the market growth include the presence of a vast patient population, the leading players, a well-developed technology, and high healthcare expenditure in the region. Moreover, the factors such as the high prevalence of diabetes and support from the companies, private organization, and government associations to improve diabetes care drives the market in the region. 

Browse Complete 85 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781 

Europe holds the next largest share in the global diabetes monitors market, the resurging economy in this region is playing a vital role in the growth of the market by availing the best possible healthcare and increasing the healthcare expenditures. Additionally, government support that encourages manufacturers of diabetes monitors to develop better devices is in turn, fostering the market growth in the region. 

The Asia Pacific region accounts for a profitable market for diabetes monitors. The increasing number of diabetic patients and rapidly improving healthcare sector are positively impacting the market growth in the region. The APAC diabetes monitors market is expected to grow at 8.9% CAGR during the period - 2017-2023.

The spreading awareness among individuals towards the advantages and the availability of these devices drives the market growth in the region. Furthermore, the increasing per capita income alongside the rising healthcare concerns are leading to increasing the market size of the diabetes monitors market. 

Global Diabetes Monitors Market – Competitive Analysis 

The highly competitive, diabetes monitors market appears to be widely expanded and fragmented characterized by the several small and large-scale companies operating the market. Well-established players incorporate strategic initiatives such as acquisition, partnership, collaboration, expansion, and product launch to gain a competitive edge and to maintain their positions in the market. 

Key Players: 

Key players leading the global diabetes monitors market include Abbott Laboratories, Panasonic, Dexcom, Inc., Medtronic, F. Hoffmann-La Roche Ltd, LifeScan, Inc., and Sanofi among others.

Industry/ Innovation/ Related News: 

January 07, 2019 –– InventHelp (USA), an inventor service firm that helps inventors announced the development of a Modified Glucose Monitor - Gluco Display – that provides an easy and effective way to assess blood glucose levels, offering an alternative to traditional glucose monitors. Gluco Display featuring a user-friendly design that is convenient and easy to use could help to reduce pain and discomfort.

January 07, 2019 –– Verily (US), a subsidiary research organization of Alphabet focused on the study of life sciences, and healthcare announced raising of USD 1 BN to support its healthcare to bolster growth in key areas such as investments in new strategic partnerships and potential acquisitions.

Verily also confirmed that it can leverage its partnerships with medical device companies Dexcom, Sanofi, and Sensile Medical to tap into a revenue stream. Verily is planning to develop devices spanning less intrusive blood glucose monitors and "all-in-one" medical-grade insulin pumps. 

Ask Any Question at https://www.marketresearchfuture.com/enquiry/4781 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Diagnostic Imaging Services Market -Covid19 Analysis, Report, Demand, Report, news Updates

Diagnostic Imaging Services Market Research Report: by Procedure (Computed Tomography, MRI, X-ray), by Application (Neurology, Oncology, Cardiology), By Service Provider (Diagnostic centres) - Global Forecast Till 2023

Market Highlights

The Global diagnostic imaging services market is projected to grow at a CAGR of 8.2% over the forecast period. In recent years, diagnostic imaging services improved their efficiency and accuracy for the of various acute and chronic diseases including cardiovascular diseases and cancer. The increasing prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field, and the on-going technological advancements in imaging services are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global diagnostic imaging services market owing to the growing clinical R&D budgets by both government as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region.  Additionally, rising prevalence of geriatric population along with various chronic diseases is contributing the growth of this market. According to a report by Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global diagnostic imaging services market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be fastest growing region is due to rising demand for imaging devices, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global diagnostic imaging services market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Segmentation

The Global diagnostic imaging services market has been segmented into procedure, application, and service provider.

By procedure, the market has been segmented into X-ray, Computed Tomography, Ultrasound, MRI (Magnetic Resonance Imaging), Nuclear Imaging, Radiography and others. The procedure segment is estimated to hold major market share in the global diagnostic imaging services market due to the rising R&D activities in the medical diagnostics field.

On the basis of application, the global diagnostic imaging services market has been segmented into Neurology, Cardiology, Oncology, Musculoskeletal and others.

The Global diagnostic imaging services market, by service provider, has been segmented into Clinics & Hospitals, Diagnostic centers, Research laboratories and others.

Company Profiles

• Center for Diagnostic Imaging (CDI)
• Medquest Associates, Inc./Novant Health
• Simonmed/Dignity Health
• Touchstone Imaging
• Alliance Medical
• Medica Group
• Sonic Healthcare
• Global Diagnostics
• Consensys Imaging Service, Inc.
• Progressive Radiology
• Concord Medical Services Holdings Limited
• Alliance Healthcare Services
• InHealth Group
• Others

Intended Audience

• Diagnostic imaging service providers
• Diagnostic imaging devices manufacturers and suppliers
• Contract Research Organizations (CROs)
• Research and Development (R&D) Companies
• Government Research Laboratories
• Independent Research Laboratories
• Government and Independent Regulatory Authorities
• Market Research and Consulting Service Providers
• Academic Institutes and Universities

Browse Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-imaging-services-market-7186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Demand on Spinal cord compression Market Trends, Growth and Report

Spinal cord compression Market Highlights

Increasing prevalence of spinal stenosis, favorable reimbursement policies, rising demands for minimally invasive therapeutic surgical procedures, and growing geriatric population is estimated to drive the market growth during the forecast period. However, lack of skilled physician, high therapeutic surgery cost and surgery-related complications are estimated to restrain the market growth during the projected period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3930

Spinal cord compression Market Segmentation

The global spinal cord compression- spinal stenosis market is segmented by type, diagnosis, treatment type, and end user.

By type, the market is segmented into lumbar spinal stenosis, cervical stenosis, central stenosis, and others. By diagnosis, the market is categorized into physical examination, imaging, and others. The imaging segment is sub-segmented into magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and others. By treatment type, the market is segmented into surgical treatment, and non-surgical treatment. The surgical treatment market is segmented into foraminotomy, laminotomy, interspinous process spacer, microendoscopic decompression, and others. By end user, the market is segmented into hospitals, ambulatory surgical centers, rehabilitation centers, and others. 

Spinal cord compression Market Regional Analysis

America dominates the global spinal cord compression-spinal stenosis market due to increasing prevalence of the spinal stenosis, presence of a well-developed healthcare sector and growing geriatric population are the factors driving the market growth within the region. Europe holds the second largest spinal cord compression- spinal stenosis market. Growing geriatric population, a well-developed healthcare sector, huge patient pool, and government support for the research and development are the major drivers within the region. On regional basis Europe is divided into Western Europe and Eastern Europe. Western Europe leads the market growth due to the presence of developed economies like U.K, France, Germany, and others within the region. On the other hand, Eastern Europe is estimated to be the fastest growing region. Asia Pacific is the fastest growing region for the market. Presence of developing economies, rising healthcare expenditure and growing geriatric population drives the market growth within the region. Middle East & Africa has the least share in the global spinal cord compression-spinal stenosis market. This can be attributed due to the presence of poor economies, low per capita healthcare expenditure, stringent government policies, especially within the African region.

Spinal cord compression Market Key Players

The key players in the global spinal cord compression- spinal stenosis market are Medtronic (U.S.), Johnson & Johnson Services Inc. (U.S.) , Stryker (U.S.), Zimmer Biomet (U.S.), NuVasive, Inc. (U.S.), Globus Medical Inc. (U.S.), Orthofix International NV (U.S.), MicroPort Scientific Corporation (China), K2M, Inc. (U.S.), Alphatec Spine, Inc. (U.S), Paradigm Spine (U.S.), and Vertos Medical Inc. (U.S.). Vertiflex Inc. (California), General Electric Company (U.S.), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Toshiba Medical Systems (Japan), Aurora Imaging Technology, Inc. (U.S.), Neusoft Corporation (China), and Neurologica Company Ltd. (London) are among others.

 List of Tables
TABLE 1 PRIMARY INTERVIEWS 20
TABLE 2 GLOBAL SPINAL CORD COMPRESSION MARKET, BY TYPE, 2014–2023 (USD MILLION) 36
TABLE 3 GLOBAL LUMBAR SPINAL STENOSIS MARKET, BY REGION, 2014–2023 (USD MILLION) 37
TABLE 4 GLOBAL CERVICAL STENOSIS MARKET, BY REGION, 2014–2023 (USD MILLION) 38
TABLE 5 GLOBAL CENTRAL STENOSIS MARKET, BY REGION, 2014–2023 (USD MILLION) 38
TABLE 6 GLOBAL SPINAL CORD COMPRESSION MARKET, BY DIAGNOSIS, 2014–2023 (USD MILLION) 39
TABLE 7 GLOBAL PHYSICAL EXAMINATION MARKET, BY REGION, 2014–2023 (USD MILLION) 40
TABLE 8 GLOBAL IMAGING MARKET, BY REGION, 2014–2023 (USD MILLION) 41
TABLE 9 GLOBAL SPINAL CORD COMPRESSION MARKET, BY TREATMENT TYPE, 2014–2023 (USD MILLION) 42
TABLE 10 GLOBAL SURGICAL TREATMENT MARKET, BY REGION, 2014–2023 (USD MILLION) 43
TABLE 11 GLOBAL SURGICAL TREATMENT MARKET, BY TYPE, 2014–2023 (USD MILLION) 44
TABLE 12 GLOBAL SPINAL CORD COMPRESSION MARKET, BY END USER, 2014–2023 (USD MILLION) 45
TABLE 13 GLOBAL HOSPITAL MARKET, BY REGION, 2014–2023 (USD MILLION) 46
TABLE 14 GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, 2014–2023 (USD MILLION) 47

Access Report Details @ https://www.marketresearchfuture.com/reports/spinal-cord-compression-spinal-stenosis-market-3930

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Retinal Disease Therapeutics Market Outlook , Global Trends, Revenue, Business Development and Forecast

 Retinal implants have cropped up as breakthrough therapy in the treatment of visual impairment. The global retinal implants market is advancing at a rapid pace and is projected to reach a significant valuation in the forthcoming years, reveals Market Research Future (MRFR) in a recently published research report.

The widespread prevalence of retinal disorders such as age-related macular degeneration and retinitis pigmentosa has generated considerable demand for retinal implants. Retinal implants have demonstrated significant restoration of vision in cases which were previously far off impossible to 
achieve.

Growing popularity of minimally invasive surgical techniques is a crucial driver of the global retinal implants market. Retinal implants do not require much invasion and can be implanted with minimal incision which makes patients opt for them.

The growth in the global retinal implants market can also be attributed to the rise in global geriatric population. The aged populace is more prone to visual impairment and acquiring retinal disorders such as age-related macular degeneration and induce high demand for diagnosis and treatment and consequently boost the growth of the Retinal Disease Therapeutics Market.

Request Free Sample @https://www.marketresearchfuture.com/sample_request/6580

Substantial investment in R&D activities by various medical device manufacturers and governments have led to the development of advanced retinal implants which can be successfully implanted in patients. Extensive clinical trial activities have also contributed to the growth of the market. Few retinal implants have already cleared clinical trials, and many more are underway which is expected to spur the market in the future. In addition, the rise in a number of FDA approvals has been a plus for the growth of the global retinal implants market.

A large number of retinal implants are due for approval and patent from various regulatory authorities, the market stores opportunities for expansion. Also, expected expansion in reimbursement coverage for retinal implants is also expected to augment the market in the coming years. Other driving factors include the rise in the prevalence of degenerative diseases and raising awareness regarding the availability of the device which raises adoption. However, lack of skilled medical professionals with adequate knowledge of performing surgery and stringent and complex FDA approval process remains a significant hurdle for the growth of the global retinal implants market. High costs associated with retinal implants, the risk of biocompatibility and unknown long-term efficacy of the product are also expected to hinder adoption.

Segmentation

The global retinal implants market has been segmented into device type, disease indication, and end user. By device type, the market has been segmented into retina implant alpha AMS, Argus II, implantable miniature telescope, and others.  By disease indication, the market has been segmented into age-related macular degeneration (AMD) and retinitis pigmentosa. By end user, the market has been segmented into multi-specialty hospitals, ophthalmic clinics, and research institutes.

Regional Analysis

North America, Europe, Asia Pacific, and the Rest of the World are the key markets for retinal implants. North America accounts for a substantial share of the global market. Higher availability of the product, improving reimbursement scenario and higher affordability in the region supports the growth of the North America market for retinal implants. Presence of highly skilled surgeons to perform immensely complex surgical procedure also accelerates adoption in the region.

In Europe, the market is driven by an increase in R&D activities and the expansion of clinical trials.

Presence of developing countries such as India, China, and Japan, who outlay massive amounts on healthcare expenditure, coupled with growing disposable income and affordability supports the growth of the market in Asia Pacific.

Rest of the World market is expected to fare well in the coming years since various market players are foraying into the untapped regions to leverage the potential they offer for market expansion.

Competitive Landscape

Second Sight Medical Products, Inc.; Retina Implant AG,  VisionCare, Inc., Bionic Vision Australia (BVA), Bionic Eye Technologies, Inc., and Visus Technology, Inc. are the key players operating in the global retinal implants market.

Access Report @ https://www.marketresearchfuture.com/reports/retinal-implants-market-6580

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Trends on Artificial Intelligence (AI) in Drug Discovery Market Size, share and Forecast

 

Artificial Intelligence (AI) in Drug Discovery Market Overview

AI drug discovery has proved itself as a vital part of the drugs industry. This technology is used for regulating drug innovation & progress costs and in decreasing the processing time. Fast adoption and other features will help the global AI in the drug discovery market to touch a 41% annual growth rate. AI method uses different algorithms for improving the drug designs, their molecular structures and classification of various forms of drugs. All of the above features are adding to the tally of the market and giving it a considerable push to reach new levels of success.

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393 

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes. 

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery. 

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market. 

 

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics; 

By Product Type    : Services and Software. 

By Molecule Type: Large and Small Molecules.

By Technology       : Machine Learning, Deep Learning, and others. 

By Indication          : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others. 

By Application       : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others. 

By End-User            : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others. 

By Regions               : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

 

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth. 

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market. 

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market. 

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket. 

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI Drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

 

AI in Drug Discovery Market   - Competitive Analysis 

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.  

https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Key Players

• Microsoft Corporation
• IBM Corporation
• Google (A Subsidiary of Alphabet Inc.)
• Atomwise, Inc.
• Deep Genomics
• Cloud Pharmaceuticals, Inc.
• Insilico Medicine
• BenevolentAI
• Exscientia
• Cyclica
• Bioage
• Numerate
• Numedii, Inc.
• Envisagenics
• Twoxar, Incorporated
• Owkin, Inc.
• Xtalpi, Inc.
• Verge Genomics
• Berg LLC

 

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:       

Akash Anand            

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Biomarker Technologies Industry at a CAGR of almost 9% during the forecast period-Industry

 The biomarker technologies market is growing pervasively at the rapid pace; mainly due to the increased research and development activities that are driven by substantial investments.  Simultaneously, the rising demand for diagnosis and treatment of diseases associated with the old age escalates the market growth on the global platform.

Acknowledging the accruals, the market is garnering currently, Market Research Future (MRFR) in its recently published study report, asserts that the growth of the global biomarker technologies will reach USD 78 BN by 2023, registering a staggering CAGR of 9 % from 2018 to 2023. 

Additional factors fostering the market growth include the widened uptake of biomarkers technologies, increasing research and development activities transpired into the field of biomarker test, growing number of contract research organizations and the cost-effective clinical trials. The spreading awareness towards the effective diagnosis processes along with the growing demand for personalized medicine is contributing to the market growth to an extent.

On the other hand, high capital investments required for the discovery, development of biomarkers, and the high cost of biomarkers are some of the factors obstructing the market growth. Nevertheless, government grants and initiatives that are undertaken to increase the R&D activities in the field are expected to support the market growth.

Market Segmentation

The global biomarker technologies Industry  is segmented based on product type, profiling technology, disease application, and research areas. 

Based on product type, the global biomarker technologies market is divided into consumables, instruments, services, and software/informatics.

Based on profiling technology, the global biomarker technologies market is segmented into imaging technology, immunoassay, PCR, NGS, chromatography, cytogenetics, mass spectrometry, and other technologies. The immunoassay segment is further segmented into ELISA, western blot, and protein microarray.

Based on disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

Based on research areas, the global market for biomarker technologies is segmented into metabolomics genomics, Proteomics, and other research areas. The metabolomics segment is further segmented into lipidomic and others.

 

Regional Analysis

Regionally, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. 

The Americas are expected to account for the largest share of the market in biomarker technologies. The growing prevalence of cancer, cardiovascular disorders, neurological and autoimmune diseases and an increasing geriatric population are likely to propel the growth of the biomarker technologies market. For example, the National Cancer Institute (NCI) reported that there were 1,666,540 new cases of cancer in the United States in 2014. As a result, this increasing patient pool is expected to accelerate market growth during the forecast period. In addition, factors such as growing government initiatives and funding for research, the development of advanced medical treatment options, and the availability of favorable refund policies are likely to fuel the growth of the biomarker technology market in the American region. In addition, according to CMS (Centers for Medicare and Medicaid Services) U.S. health care spending risen by 4.3% to reach USD 3.3 trillion per person in 2016. As a result, rising personal per capita incomes and increasing health care spending, are likely to help boost America's market growth.

Europe is the second-largest market leader and holds a healthy share of the global market for biomarker technologies. The European market is expected to have a robust growth rate during the forecast period due to the availability of extensive treatment facilities and established healthcare infrastructure, along with a growing need for an effective and accurate diagnosis. According to Cancer Research UK, around 9,921 cases were diagnosed in 2015. These increasing incidences of cancer are expected to have a substantial impact on the market for biomarker technologies due to its widespread use in cancer. This impact would boost the biomarker technologies market in Europe.

The Asia Pacific is anticipated to be the fastest emerging market in the world. Factors such as the growing prevalence of chronic diseases are the key drivers of market development. For example, as per the International Diabetes Federation, almost 382 million people worldwide had diabetes in 2013. It is expected to reach around 500 million by the end of 2035. China and India are the first and second most affected diabetes nations. Increasing numbers of diabetic patients may lead to an increase in the number of patients with cardiovascular disease. As a result, these countries are anticipated to be the fastest-growing regions due to an increasing patient pool, health awareness, and the availability of new treatment methods. Moreover, increasing healthcare expenditure and growing living standards in the region are fueling the growth of the biomarker technologies market in the Asia Pacific region.

The Middle East and Africa are expected to report the least growth in the market due to some key factors such as lack of awareness and limited access and availability of treatment facilities. Throughout the Middle East, the United Arab Emirates is the largest market due to the growth of the healthcare sector and the growing availability of specialty care centers. With an increasing number of infectious diseases in the country, several key players are eager to set up their research and development centers to find a cure for these diseases. This will boost the use of biomarkers and, as a result, a steady growth rate could be seen during the forecast period.

 

Key Players

Some of the significant participants in the global biomarker technologies market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Roche, Waters Corporation, Danaher Corporation, Shimadzu Corporation, Danaher Corporation, Siemens Healthcare.

Read More @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.